Dom Maklerski BZ WBK brokerage has issued a new report on leading Polish drug distributors, giving 'outperform' ratings to Polska Grupa Farmaceutyczna (PGF) and Farmacol. DM BZ WBK's Marcin Jabłczyński, who covers the industry has raised its target price for PGF, Poland's largest drug-store supplier to 64 zloty from 59 zloty in a research report last March. Jabłczyński expects PGF to generate net earnings of some 50 million zloty this year, excluding its latest acquisition, Apteki Polskie drugstore chain. Target price for the slightly smaller Farmacol, which has about 18 percent of the local market stayed at 33 zloty per share. That compares with yesterday's closing price of 28.8 zloty. Shares of PGF, which has just doubled its dividends to 2 zloty per share, were unchanged at 61.
Telecommunications
SM-Media down after listing on WSE
Shares of VoIP phone company SM-Media fell 6.2 percent from their last closing price on the OTC market to 64.7 zloty on their first day of trading on the Warsaw bourse on Monday. The carrier sold 100.000 shares priced at 75 zloty each in late April, raising an estimated 7.25 million zloty after IPO expenses.
Proceeds from this year's thirteenth IPO will be used to buy telecommunications hardware and to launch prepaid phone card services, SM-Media said in its filing documents.
SM-Media's stock was listed on CeTO over-the-counter market until last Friday.